These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12506775)

  • 1. Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes.
    Ramanan AV; Feldman BM
    Rheum Dis Clin North Am; 2002 Nov; 28(4):833-57. PubMed ID: 12506775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr.
    McCann LJ; Juggins AD; Maillard SM; Wedderburn LR; Davidson JE; Murray KJ; Pilkington CA;
    Rheumatology (Oxford); 2006 Oct; 45(10):1255-60. PubMed ID: 16567354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.
    Spencer CH; Rouster-Stevens K; Gewanter H; Syverson G; Modica R; Schmidt K; Emery H; Wallace C; Grevich S; Nanda K; Zhao YD; Shenoi S; Tarvin S; Hong S; Lindsley C; Weiss JE; Passo M; Ede K; Brown A; Ardalan K; Bernal W; Stoll ML; Lang B; Carrasco R; Agaiar C; Feller L; Bukulmez H; Vehe R; Kim H; Schmeling H; Gerstbacher D; Hoeltzel M; Eberhard B; Sundel R; Kim S; Huber AM; Patwardhan A;
    Pediatr Rheumatol Online J; 2017 Jun; 15(1):50. PubMed ID: 28610606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile dermatomyositis.
    Batthish M; Feldman BM
    Curr Rheumatol Rep; 2011 Jun; 13(3):216-24. PubMed ID: 21312074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.
    Wedderburn LR; Rider LG
    Best Pract Res Clin Rheumatol; 2009 Oct; 23(5):665-78. PubMed ID: 19853831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of methotrexate in inflammatory myopathies.
    Fendler C; Braun J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S164-7. PubMed ID: 21044453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The arthritis of inflammatory childhood myositis syndromes.
    Tse S; Lubelsky S; Gordon M; Al Mayouf SM; Babyn PS; Laxer RM; Silverman ED; Schneider R; Feldman BM
    J Rheumatol; 2001 Jan; 28(1):192-7. PubMed ID: 11196524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in juvenile dermatomyositis.
    Ramanan AV; Feldman BM
    Curr Opin Rheumatol; 2002 Nov; 14(6):658-62. PubMed ID: 12410087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Juvenile dermatomyositis-what's new?].
    Hinze C
    Z Rheumatol; 2019 Sep; 78(7):627-635. PubMed ID: 31087132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two children with skin rash and muscle weakness: juvenile dermatomyositis].
    Boogaard R; Drexhage VR; van Suijlekom-Smit LW
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):146-50. PubMed ID: 15693592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory myositis in children, including differential diagnosis.
    Cawkwell GM
    Curr Opin Rheumatol; 2000 Sep; 12(5):430-4. PubMed ID: 10990181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
    Feldman BM; Rider LG; Reed AM; Pachman LM
    Lancet; 2008 Jun; 371(9631):2201-12. PubMed ID: 18586175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile Idiopathic Inflammatory Myopathies.
    Huber AM
    Pediatr Clin North Am; 2018 Aug; 65(4):739-756. PubMed ID: 30031496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical spectrum of inflammatory myositis in South India--a ten year study.
    Porkodi R; Shanmuganandan K; Parthiban M; Madhavan R; Rajendran P
    J Assoc Physicians India; 2002 Oct; 50():1255-8. PubMed ID: 12568209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.
    Ramanan AV; Campbell-Webster N; Ota S; Parker S; Tran D; Tyrrell PN; Cameron B; Spiegel L; Schneider R; Laxer RM; Silverman ED; Feldman BM
    Arthritis Rheum; 2005 Nov; 52(11):3570-8. PubMed ID: 16255046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the clinical management of juvenile dermatomyositis.
    Huber AM
    Expert Rev Clin Immunol; 2018 Dec; 14(12):1021-1028. PubMed ID: 30308133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcome of children with juvenile dermatomyositis in Cape Town: a cross-sectional study.
    Okong'o LO; Esser M; Wilmshurst J; Scott C
    Pediatr Rheumatol Online J; 2016 Nov; 14(1):60. PubMed ID: 27835954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Juvenile dermatomyositis].
    Martini A; Ravelli A; Aramini L; Ramenghi B
    Pediatr Med Chir; 1990; 12(6):587-91. PubMed ID: 2093879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile dermatomyositis: Latest advances.
    Wu Q; Wedderburn LR; McCann LJ
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):535-557. PubMed ID: 29773272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.